ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 57 filers reported holding ALIGOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,517,000 | -21.4% | 127,791 | +2.8% | 0.09% | -21.9% |
Q3 2021 | $1,929,000 | -42.3% | 124,342 | -24.2% | 0.11% | -40.9% |
Q2 2021 | $3,344,000 | -20.7% | 164,051 | -11.6% | 0.19% | -24.0% |
Q1 2021 | $4,219,000 | -20.1% | 185,532 | -2.9% | 0.25% | -19.1% |
Q4 2020 | $5,283,000 | – | 191,061 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,320,381 | $2,028,013 | 4.23% |
TANG CAPITAL MANAGEMENT LLC | 3,424,800 | $2,993,275 | 0.45% |
Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $649,570 | 0.27% |
SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $552,269 | 0.23% |
Vivo Capital, LLC | 3,547,030 | $3,100,104 | 0.22% |
Newtyn Management, LLC | 1,021,461 | $892,757 | 0.18% |
Logos Global Management LP | 1,000,000 | $874,000 | 0.12% |
EcoR1 Capital, LLC | 3,948,360 | $3,450,867 | 0.11% |
HHLR ADVISORS, LTD. | 2,309,764 | $2,018,734 | 0.04% |
Baker Brothers Advisors | 2,076,400 | $1,814,774 | 0.01% |